| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/07/1998 | EP0464175B1 Extracellular form of the human fibroblast growth factor receptor |
| 01/07/1998 | EP0463110B1 Monoclonal antibodies for metallic cations |
| 01/07/1998 | EP0447424B1 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 01/07/1998 | EP0406357B1 Functional recombinantly prepared synthetic protein polymer |
| 01/07/1998 | EP0284603B1 Use of promoters of filamentous fungi |
| 01/07/1998 | CN1169754A Human interleudin-1 receptor accessory Protein |
| 01/07/1998 | CN1169753A Method for diagnose of trends of mammary gland cancer and ovary caner |
| 01/07/1998 | CN1169734A Method for purifying keratinocyte growth factors |
| 01/07/1998 | CN1169733A Analogs of keratinocyte growth factor |
| 01/07/1998 | CN1169732A Keratinocyte growth factor analogs |
| 01/07/1998 | CN1169729A Modulators functions of FAS/APOL receptors |
| 01/07/1998 | CN1169472A 新颖的雌激素受体 Novel Estrogen Receptor |
| 01/07/1998 | CN1169436A Synthesized fructosamine and preparation method thereof |
| 01/07/1998 | CN1036934C Process for preparing isohirudins with improved stability |
| 01/06/1998 | US5705732 Protection against hyperacute rejection |
| 01/06/1998 | US5705686 Inhibition of farnesyl transferase |
| 01/06/1998 | US5705617 Neurotrophic factors having altered receptor binding specificities |
| 01/06/1998 | US5705616 Proteins from yeast host strains with defects in N-glycosylation |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705612 NEF peptide encoded by human immunodefiency virus type 1 (HIV-1) |
| 01/06/1998 | US5705611 Human GM-CSF receptor component |
| 01/06/1998 | US5705610 Suspension solution, coupling, withdrawal and mixing |
| 01/06/1998 | US5705609 Decorin fragments inhibiting cell regulatory factors |
| 01/06/1998 | US5705608 Polypeptides with dna sequence codes |
| 01/06/1998 | US5705607 Procedures for the isolation and titration of sarcocystine or parasite toxin of sarcocystis genus |
| 01/06/1998 | US5705606 Polypeptides for binding aggregation mediators such as fibrogen |
| 01/06/1998 | US5705486 Anticoagulants for blood disorders |
| 01/06/1998 | US5705484 Biologically active polypeptide fusion dimers |
| 01/06/1998 | US5705483 Glucagon-like insulinotropic peptides, compositions and methods |
| 01/06/1998 | US5705481 Arginine-containing pentpeptides |
| 01/06/1998 | US5705479 Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 01/06/1998 | US5705478 Covalently linked β subunits of the glycoprotein hormones as antagonists |
| 01/06/1998 | US5705477 Compositions of transforming growth factor β(TGF-β) which promotes wound healing and methods for their use |
| 01/06/1998 | US5705389 Oligonucleotides that inhibit production of α-tumor necrosis factor |
| 01/06/1998 | US5705387 Heat-inducible N-degron module |
| 01/06/1998 | US5705380 Identification of a gene encoding TULP2, a retina specific protein |
| 01/06/1998 | US5705377 Tyrosine kinase |
| 01/06/1998 | US5705367 Neisseria having reading frames |
| 01/06/1998 | US5705364 Mammalian cell culture process |
| 01/06/1998 | US5705363 Recombinant production of human interferon τ polypeptides and nucleic acids |
| 01/06/1998 | US5705362 Modified signal sequences |
| 01/06/1998 | US5705361 Hybrid transposon with PT operon, plasmids and bacterial strains therefor |
| 01/06/1998 | US5705360 Chemokine N-terminal deletion mutations |
| 01/06/1998 | US5705359 Expression of heterologous proteins in drosophila cells |
| 01/06/1998 | US5705355 Having specified amino acid sequence; diagnosis of clot formation and separation of clotting factor |
| 01/06/1998 | US5705352 Multiple drug resistance gene of Aspergillus fumigatus |
| 01/06/1998 | US5705349 Transfection of cells, exposure to mutagenic conditions, cultures, recovering and screening |
| 01/06/1998 | US5705342 Interaction of BCL-2 and R-RAS |
| 01/06/1998 | US5705341 MDC proteins and DNAs encoding the same |
| 01/06/1998 | US5705337 Nucleic acid detection of ligands that bind covalently with target molecule complexes |
| 01/06/1998 | US5705336 Assay for sensitivity of tumors to DNA-platinating chemotherapy |
| 01/06/1998 | US5705335 Design of drugs involving receptor-ligand-DNA interactions |
| 01/06/1998 | US5705334 Uses for DNA structure-specific recognition protein |
| 01/06/1998 | US5705333 Peptide-based nucleic acid mimics(PENAMS) |
| 01/06/1998 | US5705331 HIV nucleocapsid protein capture assay and method of use |
| 01/06/1998 | US5705198 Using phospholipid dependent prothrombin activator purified from snake venom |
| 01/06/1998 | US5705197 Extraction process for producing PLGA microspheres |
| 01/06/1998 | US5705163 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 01/06/1998 | US5705161 Immunogenic meningococcal LPS and other membrane vesicles and vaccine therefrom |
| 01/06/1998 | US5705159 Immunoreactive peptide sequence from a 43 KD human cancer antigen |
| 01/06/1998 | US5705156 Pseudomonas exotoxins binding to cells |
| 01/06/1998 | US5705151 Anticarcinogenic agents using liposomes and genetic engineering |
| 01/06/1998 | US5705149 Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors |
| 01/06/1998 | US5705143 Biological targeting agents |
| 01/06/1998 | CA2108897C Genome coding phytolacca antiviral protein and a recombinant expression vector therefor |
| 01/06/1998 | CA2033814C Inhibitor of the proliferation of herpesviruses and inhibitor of the recurrence of affections caused by their latent infection |
| 01/06/1998 | CA1339623C Lhrh antagonists |
| 01/02/1998 | DE19650758C1 PKD1 protein fragments, DNA and antibodies |
| 01/02/1998 | DE19622502A1 Truncated versions of exendin peptide(s) for treating diabetes |
| 01/01/1998 | CA2205543A1 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |
| 12/31/1997 | WO1997049994A1 Method and kit for the diagnosis of troponin i |
| 12/31/1997 | WO1997049828A1 Novel tata-box binding protein-associated factors essential for yeast viability |
| 12/31/1997 | WO1997049827A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | WO1997049826A1 Living recombinant avian vaccine, using as a vector the infectious avian laryngotracheitis virus |
| 12/31/1997 | WO1997049825A1 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 12/31/1997 | WO1997049824A1 System for the production of aav vectors |
| 12/31/1997 | WO1997049822A1 Gene conferring disease resistance in plants and uses thereof |
| 12/31/1997 | WO1997049817A1 Brain glycogen phosphorylase cancer antigen |
| 12/31/1997 | WO1997049813A2 Glucuronide repressors and uses thereof |
| 12/31/1997 | WO1997049812A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 12/31/1997 | WO1997049811A1 Genetic control of flowering |
| 12/31/1997 | WO1997049810A1 Genetic control of polar auxin transport in plants and manipulation of plant growth, architecture and morphogenesis |
| 12/31/1997 | WO1997049809A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 12/31/1997 | WO1997049808A1 The caip-like gene family |
| 12/31/1997 | WO1997049807A2 A NOVEL HYPERTENSION RELATED CALCIUM REGULATED GENE (HCaRG) |
| 12/31/1997 | WO1997049806A1 Sexing gene |
| 12/31/1997 | WO1997049797A1 A cell-free system for initiation of dna replication |
| 12/31/1997 | WO1997049731A1 Cell adhesion inhibiting compounds |
| 12/31/1997 | WO1997049730A1 Method for the affinity-chromatographic purification of factor viii |
| 12/31/1997 | WO1997049729A1 Polypeptides mimicking the activity of human erythropoietin |
| 12/31/1997 | WO1997049727A1 Aatt promoter element and transcription factor |
| 12/31/1997 | WO1997049726A1 Recombinant ribosomal inhibitor protein (rip) and use as immunoconjugate |
| 12/31/1997 | WO1997049725A1 Modified factor viii |
| 12/31/1997 | WO1997049721A1 Methods of treatment of wasting syndrome based on administration of derivatives of human chorionic gonadotropin |
| 12/31/1997 | WO1997049719A1 Improved method for the production of soluble collagen |
| 12/31/1997 | WO1997049432A1 Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin |
| 12/31/1997 | WO1997049430A1 Immunotherapy by modulation of antigen presentation |
| 12/31/1997 | WO1997049425A1 Vaccine comprising antigens bound to carriers through labile bonds |
| 12/31/1997 | WO1997049417A1 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof |
| 12/31/1997 | WO1997049416A1 Recombinant vaccine for diseases caused by encapsulated organisms |